Mark G. Currie, President and CSO at Cyclerion Therapeutics, Inc. (CYCN), sold 40,214 shares at $3.01 ($121K) on 2020-12-28, disclosed to the SEC on 2020-12-30.
Open-market sale of $121k CYCN by President and CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.01 | 20,107 | $61K | 50.0% |
| 2 | $3.01 | 20,107 | $61K | 50.0% |
| Total | $3.01 avg | 40,214 | $121K | 100% |
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |
| IRWD | SELL | 2020-01-21 | $228K | — | Filing → |